Our ⭐️ & teacher of the year! Couldn’t agree more with all your points @FTaghdiri !

🧠 Wondering if a Neurohospitalist Fellowship is worth it? Dr. @FTaghdiri shares what surprised him most about his year and why it changed how he thinks about acute neurology. 🔗 Explore Accredited Programs: neurohospitalistsociety.org/… #NeurologyResident #Fellowship

Inflammatory or Not: MOG Antibody Positivity and MRI Lesion Resolution in a Mitochondrial Disorder hubs.la/Q04hYpB30 #NeuroImage

🌍 Welcome to Day 2 of #LINNCParis 2026 Today, the world comes live to Paris. For the first time, three international centers will be connected live during this morning's session: 🇮🇳 Gurugram, India - led by Gaurav Goel 🇨🇳 Shanghai, China - led by Yuxiang Gu 🇫🇷 Paris, France - led by Laurent SPELLE Bringing together expertise, innovation, and live case discussions from across the globe, this session highlights the international spirit that defines LINNC. We look forward to an exciting day of learning, collaboration, and groundbreaking discussions.

Registration is now OPEN for Autoantibody Summit 2026 on Sept 17–18 in London, ON! Focus is #Neuroimmunology with talks on #AE, #NMOSD, #MOGAD, #CIDP, #MG and other autoimmune dx. Early registration is only $200 and space is limited. Register here today: autoantibodynetwork.com/Cont…

🧠 New jobs just added to the NHS Job Board! From leadership roles to growing inpatient neurology programs, explore the latest openings in #Neurohospitalist medicine. Find your next opportunity today 👉 neurohospitalistsociety.org/… #NeuroCareers #NeurologyJobs #HospitalMedicine

A breakthrough in anti-IgLON5 disease research: patient-derived autoantibodies directly trigger neuronal hyperactivity, abnormal Tau redistribution/phosphorylation, and neuroinflammation — establishing a causal link between autoimmunity and Tau pathology. science.org/doi/10.1126/scia…

Reports of the clinician’s demise are greatly exaggerated! Happy to share this editorial, led by Dr. Buciuc, on study “MOG-IgG Positivity Does Not Equal MOGAD.” Antibody positivity and criteria are powerful tools but they do not replace clinical judgment👇thejcn.com/DOIx.php?id=10.39…

In MS research, there is a strong correlation between preventing relapses and preventing disability progression, but these authors argue tolebrutinib is unique in that it prevents progression out of proportion to its ability to prevent relapses neurology.org/doi/10.1212/CP…

Status epilepticus doesn't wait & neither can we. New research in The Neurohospitalist exposes critical gaps in refractory SE treatment across 140K hospitalizations. The need for faster, more effective therapies has never been clearer. journals.sagepub.com/doi/10.… #NeuroCriticalCare

Four million physician hours are spent on mandatory modules each year. They represent not just clinical time lost but “evenings reclaimed and cognitive load reduced.” Redundant training and low-value modules should be a thing of the past. jamanetwork.com/journals/jam…

Clinical exposure isn’t enough. In this study, diagnosing pathology in skin of colour was consistently worse than on white skin, highlighting the need for better representation in education. #MedEd @asmeofficial asmepublications.onlinelibra…

Thank you @AANmember for the platform! 🙌 NHS leadership covered it all at #AANAM, fellowship training, compensation, delirium leadership, emerging infections & more. Neurohospitalist medicine is growing, and we're proud to lead the way. #Neurohospitalist #HospitalMedicine

So exciting to see @mlevy18 present at #AANAM on satralizumab as the 1st proven treatment for attack-prevention in #MOGAD ➡️ A wonderful day for the #MOGAD community!

Congratulations to @drandrewb on receiving the 2026 @gginnovation Award! Dr. Boozary is recognized for leading the creation of Dunn House - Canada’s first hospital-led supportive housing initiative. Learn more about his trailblazing work: innovation.gg.ca/winner/dunn…

Peri-Ictal MRI Abnormalities and Risk of Unprovoked Seizures After De Novo Status Epilepticus: hubs.la/Q049Cj0R0

Expanding the Clinicoradiologic Phenotype of the CTSA-Associated Small Vessel Disease CARASAL: A Comparison With CADASIL hubs.la/Q049C7M10

Don’t miss SS8: Beyond the Buzz at #AANAM. Great to see Robert De Santis, MD, Neurohospitalist Fellow at @StanfordMed, featured on this panel exploring alcohol’s neurologic effects from clinic to ICU. #Neurohospitalist #Neurology #NeurocriticalCare